# Randomization and Blinding in Experimental Design

In the 1990s, a series of clinical trials testing antiarrhythmic drugs showed a disturbing pattern: in unblinded trials, the drugs appeared to work; in double-blind trials, some of the same drugs increased patient mortality. The discrepancy was not fraud. It was the perfectly ordinary human tendency to interpret ambiguous information in the direction of expectation — applied, in an unblinded setting, to decisions that affected whether patients lived or died. Randomization and blinding are the experimental design practices that prevent systematic bias — the type of error that cannot be corrected by increasing sample size because it affects all samples in the same direction. While these practices are well established in clinical trials and are increasingly standard in animal studies, they are often absent from cell biology and biochemistry experiments. This is a major source of unreproducible results.

## What Systematic Bias Is and Why It Matters

Random error (measurement noise, biological variability) averages out across a sufficiently large sample. Systematic bias does not — it shifts all measurements in the same direction, producing results that are consistently wrong in a predictable way. Because systematic bias does not average out, it cannot be overcome by increasing n. The only solutions are to eliminate bias by design (randomization) or to minimize its effect on conclusions (blinding).

**Common sources of systematic bias in biology:**

- **Batch effects:** Samples prepared or analyzed on different days, by different operators, using different reagent lots tend to differ from each other in ways unrelated to the experimental variable. If all control samples are processed in batch 1 and all experimental samples in batch 2, any batch difference is confounded with the treatment effect.
- **Cage effects:** In animal studies, all animals in one cage share a microenvironment (cage bedding, position in the rack, social hierarchy). Assigning all control animals to one cage and all experimental animals to another means the "treatment" effect includes all cage-level differences.
- **Investigator effects:** Researchers unconsciously handle animals, cells, or samples differently depending on their expectations. This is a major source of bias in behavioral assays and in assays requiring skilled manual procedures.
- **Equipment drift:** Instruments that drift over time (flow cytometers, plate readers, sequencers) will produce systematically different values for samples measured at the beginning vs. end of a run.

## Randomization: Preventing Confounding

**Randomization** means randomly assigning subjects or samples to experimental conditions, or randomly ordering the processing of samples. Its purpose is to prevent any systematic relationship between the assignment to groups and any unmeasured variable that could influence the outcome.

### Randomization in animal experiments

In a mouse experiment comparing two conditions:

**Do not do this:** Assign the first 10 mice from the cage to the control group and the next 10 to the treatment group. If mice at the top of the cage are exposed to more light or are more dominant, this creates a systematic difference.

**Do this instead:** Use a random number table or random number generator to assign mice to groups. R code: `sample(c(rep("control", 10), rep("treatment", 10)))`. Use cage as a blocking factor and randomize within cages (see below).

**Randomize order of treatment administration:** If gavaging 20 mice with vehicle or drug, randomize the order in which you treat animals. If treatment takes 30 minutes per animal, a systematic order (all controls first, all treatments last) means treatment animals receive drug 2 hours after feeding, while controls receive vehicle immediately after feeding — a confounder.

### Randomization in cell culture experiments

Even in cell culture, randomization matters:

- **Plate position effects:** Outer wells of 96-well plates often evaporate faster (edge effect), leading to higher concentrations and different read values. Randomize sample positions across the plate rather than clustering all controls in column 1 and all treatments in columns 2–12.
- **Processing order:** If you are processing 24 samples, randomize the order in which you process them so that the first and last samples are not systematically from the same condition.
- **Gel loading in Western blotting:** Randomize the lane assignment of control and experimental lysates so that gel position effects are not confounded with treatment.

### Blocking + randomization

When an experiment has a known source of variation that cannot be eliminated (e.g., three different operators, or processing over three days), use a **randomized block design**: include samples from all conditions in each block (day, operator, plate), and randomize assignment within each block.

This ensures that any systematic difference between blocks affects all conditions equally and can be statistically accounted for as a block effect in the analysis (using a mixed-effects model or ANOVA with block as a factor).

**Example:** RNA-seq experiment across 3 days of library preparation. Rather than preparing all control samples on Day 1 and all treatment samples on Day 2, include both control and treatment samples on each day, with randomized assignment.

## Blinding: Preventing Observer Bias

**Blinding** means that the person analyzing the data does not know which samples belong to which experimental group at the time of analysis. It prevents the analyst from unconsciously (or consciously) making analytical decisions that favor the expected result.

### Why blinding matters

Consider a behavioral assay where a researcher observes and scores mice for signs of neurological deficit. Even the most careful researcher, knowing which mice received treatment, will make marginally different scoring decisions in ambiguous cases — and in behavioral scoring, most cases are ambiguous. Over many ambiguous calls, this systematic bias accumulates into a consistent skew favoring the expected result.

This is not dishonesty — it is an inherent feature of human cognition. The appropriate response is blinding, not asking researchers to try harder to be unbiased.

### How to implement blinding

**Animal experiments:** Assign cage cards with coded identifiers (A001, A002, etc.) rather than treatment labels ("control," "drug"). Have a different team member hold the randomization key. The researcher conducting behavioral scoring and the researcher performing tissue analysis should not know the group assignments until the data has been collected and locked.

**Image analysis:** Present images to the analyst as coded files (001.tiff, 002.tiff, etc.) rather than named by condition. This is easily implemented by having a lab member rename files before analysis.

**Histological scoring:** Tissue sections should be scored by a pathologist who is blinded to treatment condition. This is standard in clinical trials and should be standard in animal studies.

**Flow cytometry gating:** Gating decisions (which cells to include in each population) can introduce large biases. Set gates blindly on unstained controls and single-color controls, then apply the same gates to all samples. Do not adjust gates after seeing the data from experimental conditions.

**Computational analysis:** For computational analyses (differential expression, sequence alignment, machine learning), blinding is not typically applicable because the algorithm does not have human bias — but the human selecting which samples to include or exclude can introduce bias. Pre-specify inclusion/exclusion criteria before analyzing data.

### Single-blind vs. double-blind

- **Double-blind:** Neither the person administering the treatment nor the person assessing the outcome knows the group assignment. Gold standard for clinical trials.
- **Single-blind (investigator-blind):** The researcher analyzing outcomes is blinded; the person administering treatment may know the assignment. Standard for animal studies where full double-blinding is impractical.

### Unblinding

Data analysis should be conducted in a blinded fashion until the dataset is complete and locked. **Unblinding** (revealing group assignments) should occur only after the analysis plan has been executed. Any changes to the analysis plan after unblinding should be flagged as post-hoc and treated with appropriate skepticism.

## Reporting Randomization and Blinding

ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) require explicit statements of randomization and blinding in animal studies. Even outside of animal research, papers should state:

- "Animals were randomized to treatment groups using a random number generator prior to the start of the experiment."
- "Behavioral scoring was performed by an investigator blinded to treatment assignment."
- "Sample identities were concealed from the analyst until data collection was complete."

Absence of these statements in a paper about animal behavioral or pharmacological studies should reduce your confidence in the results.

## Takeaway

Randomization and blinding are the design-level defenses against systematic bias — the bias that cannot be corrected by more data. Randomization prevents the confounding of treatment with any unmeasured variable; blinding prevents observer bias from influencing analytical decisions. Both practices are standard in clinical trials and increasingly required in preclinical animal research. Implementing them in cell biology and biochemistry, though less traditional, is equally valuable and often feasible with minimal additional effort.
